{
  "kind": "treatment",
  "slug": "hydroxyzine-vistaril",
  "type": "anxiolytic",
  "name": "Hydroxyzine (Vistaril)",
  "summary": "An antihistamine with anxiolytic and sedative properties used for anxiety, pruritus, and insomnia.",
  "description": "Hydroxyzine is a first-generation antihistamine that blocks histamine H1 receptors. It also has anticholinergic and sedative properties, making it useful in the short-term management of anxiety, allergic conditions, and insomnia. Vistaril is a commonly known brand name for the pamoate salt formulation, often used in psychiatry as a non-habit-forming anxiolytic.",
  "category": "medications/anxiolytics",
  "tags": [
    "antihistamine",
    "anxiolytic",
    "sedative",
    "insomnia",
    "pruritus"
  ],
  "metadata": {
    "drug_classes": [
      "Antihistamine",
      "Anxiolytic",
      "Sedative"
    ],
    "therapeutic_categories": [
      "Anxiety Disorders",
      "Sleep Disorders",
      "Allergic Conditions",
      "Dermatologic Conditions"
    ],
    "mechanism_categories": [
      "Other"
    ],
    "administration_routes": [
      "Oral",
      "Injection"
    ],
    "prescription_status": "Prescription Required",
    "controlled_substance": false,
    "generic_available": true,
    "brand_names": [
      "Vistaril",
      "Atarax"
    ],
    "dea_schedule": null,
    "fda_pregnancy_category": "C",
    "age_groups": [
      "Adult",
      "Pediatric",
      "Geriatric"
    ],
    "treatment_duration": [
      "Short-term"
    ],
    "specialty_areas": [
      "Psychiatry",
      "Primary Care",
      "Dermatology",
      "Allergy and Immunology"
    ],
    "fda_approval_year": 1956
  },
  "clinical_metadata": {
    "primary_indications": [
      "Anxiety",
      "Other",
      "Insomnia"
    ],
    "off_label_uses": [
      "Nausea and vomiting",
      "Preoperative sedation",
      "Substance withdrawal symptoms"
    ],
    "contraindications": [
      "Early pregnancy (first trimester)",
      "Hypersensitivity to hydroxyzine or cetirizine",
      "QT prolongation history"
    ],
    "monitoring_required": [
      "Sedation level",
      "Anticholinergic effects",
      "Cardiac conduction (if at risk for QT prolongation)"
    ],
    "efficacy_rating": {
      "anxiety": 3,
      "insomnia": 3,
      "pruritus": 4
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "hydroxyzine",
      "vistaril",
      "atarax",
      "antihistamine",
      "anxiolytic",
      "sedative"
    ],
    "synonyms": [
      "hydroxyzine pamoate",
      "hydroxyzine hydrochloride"
    ],
    "common_misspellings": [
      "hydroxizine",
      "hydroxyzene"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Generalized Anxiety Disorder (GAD)",
        "Acute anxiety episodes",
        "Pruritus due to allergic conditions",
        "Short-term insomnia"
      ]
    },
    {
      "type": "mechanism",
      "text": "Blocks histamine H1 receptors in the CNS and periphery; also exhibits anticholinergic and sedative effects."
    },
    {
      "type": "dosing",
      "adult": {
        "anxiety": "50–100 mg/day in divided doses",
        "pruritus": "25 mg three to four times daily",
        "insomnia": "50 mg at bedtime"
      },
      "pediatric": {
        "anxiety": "0.5–1 mg/kg every 6 hours as needed",
        "pruritus": "0.5 mg/kg every 6 hours"
      },
      "geriatric": "Use lower initial doses due to increased sensitivity to sedation",
      "hepatic_impairment": "Reduce dose; increased half-life in hepatic dysfunction",
      "renal_impairment": "Use with caution"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Capsules (pamoate): 25 mg, 50 mg, 100 mg",
        "Tablets (hydrochloride): 10 mg, 25 mg, 50 mg",
        "Oral suspension: 10 mg/5 mL",
        "Intramuscular injection: 25 mg/mL, 50 mg/mL"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Onset within 15–30 minutes; duration 4–6 hours (may be longer in elderly)."
    },
    {
      "type": "adverse_effects",
      "common": [
        "drowsiness",
        "dry mouth",
        "dizziness",
        "headache"
      ],
      "less_common": [
        "blurred vision",
        "urinary retention",
        "confusion (elderly)"
      ],
      "serious": [
        "QT prolongation",
        "torsades de pointes (rare)"
      ]
    },
    {
      "type": "warnings",
      "black_box": null,
      "other": [
        "Avoid in first trimester of pregnancy",
        "May cause additive CNS depression with alcohol or sedatives",
        "Caution in elderly due to anticholinergic burden"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "Alcohol",
          "risk": "Increased CNS depression",
          "action": "Avoid combination"
        },
        {
          "with": "Other CNS depressants",
          "risk": "Enhanced sedation",
          "action": "Use caution"
        },
        {
          "with": "QT-prolonging drugs",
          "risk": "Additive QT prolongation",
          "action": "Avoid or monitor"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Sedation level",
        "Anticholinergic effects",
        "ECG if at risk for QT prolongation"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Avoid in early pregnancy; later use only if benefits outweigh risks",
      "lactation": "Excreted in breast milk; may cause sedation in infant",
      "pediatrics": "Avoid in neonates due to CNS depression risk",
      "geriatrics": "Lower doses recommended to reduce sedation and fall risk"
    },
    {
      "type": "tapering",
      "text": "No physiological dependence expected; abrupt cessation is safe."
    },
    {
      "type": "clinical_notes",
      "items": [
        "Useful for patients with anxiety who cannot take benzodiazepines",
        "Can be prescribed as an as-needed anxiolytic",
        "Also marketed as Atarax (hydrochloride salt) in some regions"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "Vistaril Prescribing Information",
          "url": "https://www.accessdata.fda.gov/"
        },
        {
          "label": "APA Anxiety Disorder Guidelines",
          "url": "https://www.psychiatry.org/"
        }
      ]
    }
  ],
  "seo": {
    "title": "Hydroxyzine (Vistaril): Anxiolytic & Antihistamine",
    "description": "Hydroxyzine (Vistaril) is an antihistamine used for anxiety, pruritus, and insomnia, offering sedative effects without risk of dependence."
  }
}
